These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt. Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896 [TBL] [Abstract][Full Text] [Related]
5. Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists? Savić MM; Huang S; Furtmüller R; Clayton T; Huck S; Obradović DI; Ugresić ND; Sieghart W; Bokonjić DR; Cook JM Neuropsychopharmacology; 2008 Jan; 33(2):332-9. PubMed ID: 17392731 [TBL] [Abstract][Full Text] [Related]
6. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties. Araujo F; Ruano D; Vitorica J J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469 [TBL] [Abstract][Full Text] [Related]
7. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors. Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950 [TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105 [TBL] [Abstract][Full Text] [Related]
9. The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated. Atack JR; Bayley PJ; Fletcher SR; McKernan RM; Wafford KA; Dawson GR Eur J Pharmacol; 2006 Oct; 548(1-3):77-82. PubMed ID: 16962577 [TBL] [Abstract][Full Text] [Related]
11. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077 [TBL] [Abstract][Full Text] [Related]
12. Closing the gap between the molecular and systemic actions of anesthetic agents. Antkowiak B Adv Pharmacol; 2015; 72():229-62. PubMed ID: 25600373 [TBL] [Abstract][Full Text] [Related]
13. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon. Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350 [TBL] [Abstract][Full Text] [Related]
18. Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. Barbee JG J Clin Psychiatry; 1993 Oct; 54 Suppl():86-97; discussion 98-101. PubMed ID: 8262893 [TBL] [Abstract][Full Text] [Related]
19. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis. Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648 [TBL] [Abstract][Full Text] [Related]
20. GABA-A receptor complex and memory processes. Chapouthier G; Venault P Curr Top Med Chem; 2002 Aug; 2(8):841-51. PubMed ID: 12171575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]